APA (7th ed.) Citation

Garcia-Manero, G., Yang, H., Fang, Z., Kantarjian, H. M., DiNardo, C. D., Jabbour, E. J., . . . Paradiso, L. J. (2016). Phase 1 Results of FF-10501-01, a Novel Inosine 5'-Monophosphate Dehydrogenase Inhibitor, in Advanced Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS), Including Hypomethylating Agent (HMA) Failures. Blood, 128(22), 1640. https://doi.org/10.1182/blood.V128.22.1640.1640

Chicago Style (17th ed.) Citation

Garcia-Manero, Guillermo, et al. "Phase 1 Results of FF-10501-01, a Novel Inosine 5'-Monophosphate Dehydrogenase Inhibitor, in Advanced Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS), Including Hypomethylating Agent (HMA) Failures." Blood 128, no. 22 (2016): 1640. https://doi.org/10.1182/blood.V128.22.1640.1640.

MLA (9th ed.) Citation

Garcia-Manero, Guillermo, et al. "Phase 1 Results of FF-10501-01, a Novel Inosine 5'-Monophosphate Dehydrogenase Inhibitor, in Advanced Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS), Including Hypomethylating Agent (HMA) Failures." Blood, vol. 128, no. 22, 2016, p. 1640, https://doi.org/10.1182/blood.V128.22.1640.1640.